Blood Biomarkers for Neurodegeneration

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

198 papers

Showing 61-72 of total 198 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedSupporting evidence

Incidence of dementia and mild cognitive impairment in two Indigenous Bolivian cohorts.

Gatz M; Mack WJ; Eid Rodriguez D; Quispe Gutierrez R; Bani Cuata J; Chui HC; Walters EE; Cummings DK; Hooper PL; Zetterberg H; Finch CE; Trumble BC; Stieglitz J; Gurven MD; Thompson RC; Thomas GS; HORUS Team; Tsimane Health and Life History Project; Kaplan HS

Jan 1, 2026Alzheimer's & dementia : the journal of the Alzheimer's Association

2026PubMedSupporting evidence

Changes in five cerebrospinal fluid and three plasma Alzheimer's disease biomarkers across increasing brain amyloid-beta and tau pathology burden.

Mastrangelo A; Baiardi S; Ruggeri E; Bentivenga GM; Vargiu CM; Mammana A; Sbriccoli M; Polischi B; Carlà B; Capellari S; Parchi P

Jan 1, 2026Acta neuropathologica

2026PubMedSupporting evidence

Chronic kidney disease and cognitive decline: choroid plexus remodeling, glymphatic dysfunction, and alzheimer biomarker interpretation.

Corrêa LMA; Oliveira da Silva R; Brandão LKV; Delmiro Silva YR; da Silva ÉVB; Tretow J; Gomes EDC; Fernandes CCS; Moreira GNCM; Zanella J

Jan 1, 2026Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

2026PubMedSupporting evidence

Stage-dependent associations of glial fibrillary acidic protein and chitinase-3-like protein 1 with white matter network integrity in Alzheimer's disease.

Li OY; Turnbull A; Vankee-Lin F

Jan 1, 2026Journal of Alzheimer's disease : JAD

2026PubMedSupporting evidence

Baseline plasma C1q and C3 as potential biomarkers for lecanemab efficacy and ARIA risk in early Alzheimer's disease.

Byeon G; Lee JW; Kim S; Um YH; Wang SM; Ha S; Park SY; Shin I; Jang J; Lee CU; Lim HK; Kang DW

Jan 1, 2026Alzheimer's & dementia (New York, N. Y.)

2026PubMedSupporting evidence

Parkinson's disease diagnosis using machine learning and multimodal biomarkers: A systematic review.

Khan MI; Imran A; Alshammari A

Jan 1, 2026Computational biology and chemistry

2026PubMedSupporting evidence

Hippocampal mediation in the lipid-Alzheimer's disease pathway: A high-dimensional mediation analysis stratified by APOE and sex.

Cao Y; Fan Y; Meng Q; Wang J; Chen R; Alzheimer's Disease Neuroimaging Initiative; Alzheimer's Disease Metabolomics Consortium

Jan 1, 2026Alzheimer's & dementia (New York, N. Y.)

2026PubMedSupporting evidence

Associations between serum estradiol and estrone and Alzheimer's disease biomarkers: An analysis in female participants from the European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS).

Shin J; Muniz-Terrera G; Ritchie CW; Manson J; Plachecki S; Kirschbaum C; Gregory S

Jan 1, 2026Alzheimer's & dementia : the journal of the Alzheimer's Association

2026PubMedDirectly related

Exploring TIMP2 genetics and CSF levels in Parkinson's disease: biomarkers of neurodegeneration and ageing.

Zimmermann M; Fandrich M; Schulte C; Jakobi M; Wurster I; Lerche S; Zimmermann S; Deuschle C; Schneiderhan-Marra N; Joos TO; Gasser T; Brockmann K; Roeben B

Jan 1, 2026GeroScience

2026PubMedDirectly related

Resilience mechanisms in Parkinson's disease: a domain-specific conceptual framework.

Ruppert-Junck MC; van Eimeren T; Giehl K; Helmich RC; Hönig M; Johansson ME; Mitterová K; Rektorová I; Waldthaler J; Pedrosa D; TRACE-PD consortium; the

Jan 1, 2026Brain : a journal of neurology

2026PubMedDirectly related

Effects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trial.

Pike JR; Huang AR; Reed N; Arnold ML; Chisolm TH; Couper D; Deal JA; Faucette S; Goman AM; Gottesman RF; Hughes TM; Knopman D; Mitchell C; Mosley TH; Palta P; Pankow JS; Sanchez VA; Selvin E; Sullivan KJ; Thyagarajan B; Wagenknecht LE; Lin FR; Coresh J; ACHIEVE Collaborative Research Groups; ACHIEVE Collaborative Research Group

Jan 1, 2026EClinicalMedicine

2026PubMedSupporting evidence

Associations of plasma lipid burden with cognitive performance and decline across dementia with Lewy bodies, Alzheimer's disease, and Parkinson's disease dementia.

Su Z; Liu M; Su L; Kuai J; Xu B; Wang C; Su M; Zheng Y; Peng J; Bao X; Zuo M; Guo X

Jan 1, 2026Journal of Alzheimer's disease : JAD